Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-12

Clinical Trial Update: Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

View source ↗

Summary

Natera's colorectal cancer screening test (FIND-CRC) is currently recruiting in an average-risk population to evaluate its performance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Natera, Inc. | Conditions: Colo-rectal Cancer | Status: RECRUITING